Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
Crossref DOI link: https://doi.org/10.1186/s13075-019-1850-x
Published Online: 2019-02-25
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cavalli, Giulio
Tomelleri, Alessandro
De Luca, Giacomo
Campochiaro, Corrado
Dinarello, Charles A.
Baldissera, Elena
Dagna, Lorenzo
Text and Data Mining valid from 2019-02-25
Article History
Received: 19 February 2019
Accepted: 19 February 2019
First Online: 25 February 2019